Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
21 Results for "
apoA-I
" in MedChemExpress (MCE) Product Catalog:
Products (21)
21 Results for "apoA-I" in MCE Product Catalog:
3
3 Cited Publications
Cat. No.: HY-19900
CAS No.: 1252679-52-9
Research Areas:
ITX5061 is an orally active type II non-competitive p38 MAPK inhibitor. ITX5061 increases HDL-C levels by inhibiting SR-BI activity. ITX5061 also moderately elevates ApoA-I levels. ITX5061 reduces early atherosclerotic lesions in the aortic arch of mice fed an atherogenic diet. ITX5061 can be used in the research of atherosclerosis .
3
2
1
1
Cat. No.: HY-P5282
CAS No.: 221882-20-8
Target:
Research Areas:
Cat. No.: HY-P10551
Research Areas:
ApoA-I mimetic peptide 5A is an ApoA-I mimetic peptide and ABCA1 activator. ApoA-I mimetic peptide 5A enhances CD36 expression through the JAK2/STAT3 signaling pathway. ApoA-I mimetic peptide 5A promotes cholesterol efflux, remyelination, and myelin debris clearance/degradation. ApoA-I mimetic peptide 5A can be used in research on inflammatory bowel disease, demyelinating diseases, and atherosclerosis .
Cat. No.: HY-P6365B
CAS No.: 452782-06-8
Synonyms: D-4F
Target:
Research Areas:
Cat. No.: HY-113510
CAS No.: 89886-42-0
Cat. No.: HY-W590664
CAS No.: 13031-64-6
Target:
Research Areas:
C2 Dihydroceramide is a derivative of C2 Ceramide (HY-101180). C2 Dihydroceramide enhances the ABCA1-mediated cholesterol efflux to apolipoprotein A-I (apoA-I) without causing cytotoxicity .
Cat. No.: HY-117555
CAS No.: 1415477-76-7
Research Areas:
4010B-30 is a upregulator of apolipoprotein A-I (ApoA-I). 4010B-30 regulates ApoA-I gene expression through activation of PPARγ. 4010B-30 promotes cholesterol efflux and ABCA1 expression. 4010B-30 protects against atherosclerotic lesion development in ApoE -/- mice .
Cat. No.: HY-P706290
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: ¹⁵N-Recombinant Human Apolipoprotein A1; ¹⁵N-rhapoA-I; apoA1; apoA1 Protein; Apolipoprotein A1; Apo(A); Apolipoprotein A-I; HPALP2; Apo-AI; AMYLD3; Epididymis Secretory Sperm Binding Protein; apoA-I
Species:
Human
Source:
HEK293
Cat. No.: HY-P75503A
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: apoA1; apoA1 Protein; Apolipoprotein A1; Apo(A); Apolipoprotein A-I; HPALP2; Apo-AI; AMYLD3; Epididymis Secretory Sperm Binding Protein; apoA-I
Species:
Mouse
Source:
HEK293
Cat. No.: HY-122068
CAS No.: 848144-15-0
Research Areas:
ITX5061 free base is an orally active type II non-competitive p38 MAPK inhibitor. ITX5061 free base increases HDL-C levels by inhibiting SR-BI activity. ITX5061 free base also moderately elevates ApoA-I levels. ITX5061 free base reduces early atherosclerotic lesions in the aortic arch of mice fed an atherogenic diet. ITX5061 free base can be used in the research of atherosclerosis .
Cat. No.: HY-P12259
Research Areas:
4F-P-4F peptide is an apoA-I mimetic peptide with a class A amphipathic α-helical structure that acts on ABCA1 and SR-B. 4F-P-4F peptide induces cholesterol efflux from cholesterol-loaded mouse macrophages and promotes HDL remodeling in plasma. 4F-P-4F peptide can be used in research on asthma and atherosclerosis .
Cat. No.: HY-RS23521
Target:
Research Areas:
Apoa1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Apoa1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
